Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors

AIDS. 2006 Mar 21;20(5):775-8. doi: 10.1097/01.aids.0000216380.30055.4a.

Abstract

In this study we characterized factors associated with the late initiation of HIV care in the southeastern United States. At initiation of care, antiretroviral therapy was indicated for 75% of patients, 50% had a CD4 cell count of less than 200 cells/mul, and 27% presented with an AIDS-defining illness. Male sex was an independent predictor in multivariable analysis. These results indicate an urgent need to increase HIV testing for earlier diagnosis in the southeastern USA.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV-1* / genetics
  • Humans
  • Immunosuppression Therapy
  • Logistic Models
  • Male
  • North Carolina
  • Patient Selection
  • RNA, Viral / blood
  • Risk Factors
  • Sex Factors
  • Time Factors

Substances

  • Anti-Retroviral Agents
  • RNA, Viral